Cyanotech (CYAN) Stock Price, News & Analysis

Company Overview

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

Key Stats

• Today's Range: $0.38 to $0.38
• 50-Day Range: $2.83 to $3.26
• 52-Week Range: $2.37 to $6.29
• Volume: 3,000 shs
• Average Volume: 6,378 shs
• Market Capitalization: $2.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CYAN Stock Analysis - Frequently Asked Questions

How were Cyanotech's earnings last quarter?

Cyanotech Co. (NASDAQ:CYAN) released its earnings results on Tuesday, August, 11th. The biotechnology company reported $0.02 earnings per share for the quarter. The biotechnology company earned $7.35 million during the quarter. Cyanotech had a negative net margin of 23.41% and a negative trailing twelve-month return on equity of 47.42%.

What other stocks do shareholders of Cyanotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clarivate (CCC), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL).

Company Calendar

• Last Earnings: 8/11/2020
• Today: 11/24/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medicinals & botanicals
• Sub-Industry: N/A
• Current Symbol: NASDAQ:CYAN
• CUSIP: N/A
• CIK: 768408
• Web: www.cyanotech.com
• Phone: (808) 326-1353
• Fax: 808-329-4533
• Employees: 95
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.79)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-5,270,000.00
• Net Margins: -23.41%
• Pretax Margin: -23.39%
• Return on Equity: -47.42%
• Return on Assets: -21.66%

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 1.06
• Quick Ratio: 0.31

Sales & Book Value

• Annual Sales: $23.07 million
• Price / Sales: 0.12
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.35 per share
• Price / Book: 0.28

Miscellaneous

• Outstanding Shares: 7,160,000
• Free Float: 5,074,000
• Market Cap: $2.72 million
• Optionable: Not Optionable
• Beta: 0.02